Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Net Margin Over TimeContracting
Percentile Rank93
3Y CAGR+24.2%
Studio
Year-over-Year Change

Net income as a percentage of revenue

3Y CAGR
+24.2%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM4.31%-62.3%
202411.43%+113.9%
2023-81.92%-3739.9%
20222.25%+100.2%
2021-1198.32%-352.0%
2020-265.14%-
20190.00%+100.0%
2018-500916.67%-23550.7%
2017-2117.98%+50.1%
2016-4246.87%-